Dirk Lange (KBI)

KBI plans $150M fa­cil­i­ty in Re­search Tri­an­gle Park with mys­tery co-in­vestor

A month af­ter un­veil­ing plans for a new man­u­fac­tur­ing fa­cil­i­ty in Gene­va, KBI Bio­phar­ma has al­ready pegged the lo­ca­tion for its next site: a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA